A10-基础胰岛素的理想选择(专家版).pptVIP

And in nearly every case where the variability of FBG has been measured in terms of SD, there has been a significant advantage for IDet. In the one study where there was no significant difference in this parameter, there was a significant difference in pre-dinner BG variability. This study was atypical as it employed a treat-to-target protocol adding IDet or NPH as an insulin supplement to OADs in poorly controlled type 2 diabetes. It is noteworthy that variability is in any case consistently lower in the type 2 diabetes trials. Speculatively, this might reflect the ability of endogenous in